Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)
 
 • Company Description   
agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States.

Number of Employees: 856

 
 • Price / Volume Information   
Yesterday's Closing Price: $84.14 Daily Weekly Monthly
20 Day Moving Average: 224,222 shares
Shares Outstanding: 16.79 (millions)
Market Capitalization: $1,412.81 (millions)
Beta: 2.98
52 Week High: $133.04
52 Week Low: $7.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.93% -4.98%
12 Week -26.74% -28.14%
Year To Date 388.69% 333.18%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
440 Polaris Parkway Suite 550
-
Westerville,OH 43082
USA
ph: 562-256-3800
fax: -
investors@agilonhealth.com http://agilonhealth.com
 
 • General Corporate Information   
Officers
Ronald A. Williams - Chairman
Ravi Sachdev - Vice Chairman
Jeffrey Schwaneke - Chief Financial Officer
Timothy Gertsch - Chief Accounting Officer
Sharad Mansukani - Director

Peer Information
Agilon Health, Inc. (CHCR)
Agilon Health, Inc. (ESRX)
Agilon Health, Inc. (MYDP)
Agilon Health, Inc. (COR)
Agilon Health, Inc. (GBCS)
Agilon Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 00857U206
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/03/26
Share - Related Items
Shares Outstanding: 16.79
Most Recent Split Date: 3.00 (0.04:1)
Beta: 2.98
Market Capitalization: $1,412.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-3.65 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.90 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.21
Price/Cash Flow: -
Price / Sales: 0.24
EPS Growth
vs. Year Ago Period: 116.64%
vs. Previous Quarter: -42.22%
Sales Growth
vs. Year Ago Period: 7.15%
vs. Previous Quarter: 5.23%
ROE
09/30/26 - -
06/30/26 - -119.38
03/31/26 - -146.03
ROA
09/30/26 - -
06/30/26 - -16.85
03/31/26 - -24.55
Current Ratio
09/30/26 - -
06/30/26 - 1.08
03/31/26 - 1.04
Quick Ratio
09/30/26 - -
06/30/26 - 1.08
03/31/26 - 1.04
Operating Margin
09/30/26 - -
06/30/26 - -4.24
03/31/26 - -6.42
Net Margin
09/30/26 - -
06/30/26 - -3.92
03/31/26 - -6.09
Pre-Tax Margin
09/30/26 - -
06/30/26 - -4.23
03/31/26 - -6.40
Book Value
09/30/26 - -
06/30/26 - 13.55
03/31/26 - 10.89
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.07
03/31/26 - 0.08
Debt-to-Capital
09/30/26 - -
06/30/26 - 6.33
03/31/26 - 7.77
 

Powered by Zacks Investment Research ©